No offense intended. I think most of you guys know I've been trading this stock. A couple days this close to results is like a year to me.
pivalde - I agree - pretty conservative. I tried to recommend your post on my iPad and it registered as a thumbs down. You would think the geniuses that designed this site would have bata tested it.
I think most investors were expecting it. Accounts for the weakness. Pretty conservative dilution wise.
The effect might be less than if they had diluted at a higher price or at a discount.
They might announce results sooner than I expected.
Hi kad - I think Tanzi's "lightening doesn't strike twice" comment has validity. The odds of PBT2 showing a significant effect on cognition in a 12 month trial are better than they were previously. How the market and potential partners react to the trial results will probably come down to the magnitude and durability of the effect.
I don't quite understand the logic in buying March calls. The company guided results in March which means the results could come anytime this month. I can think of a number of scenarios (besides the one we are experiencing) which made the March calls undesirable.
Apparently there were many investors that thought it was a good call but I don't understand the logic.
The bar for advancement is low but not as low as some might think. There is a threshold for all the end points.
The problem is this is a really small trial which makes it more difficult to show statistical efficacy.
We know the drug has positive activity.
I am not an authority on the subject but I've been trading biotech over 30 years.
The HD trial was not a candidate for an extension.
The HD trial was primarily for safety, practically a phase 1. These types of trials do not have extensions unless they are much more efficacious in a life threatening indication. Forget your thought. The trial was never going to have an extension.
All we can do is speculate. I am probably not the only one expecting results sometime between March 21st and the end of the month. The short interest temporarily took over in response to the time element and decent (but not strong) HD trial results.
This run-up has already dwarfed the previous one in 2007. The program is further along now and if this trial has good results the drug (in all likelihood) will be partnered.
I don't think we have seen the pre-results high yet. We probably have at least 8 trading days to go. My target is $15-17.50.
I'll bet Matt caused like one or two people to sell? Those 10 shares snowballed into a downward trade.
I'm going to buy 10 shares right now and see if I can get the stock back over 12.
Where's the caveman?
"Matt was the lead whiner who changed the board sentiment and brought out the rest of the fence sitters, planting doubt and consequently tanking the stock."
Wow, Matt tanked the stock! LOL
I know what opening range means. Forget digesting the news. The stock is going to gap way down if the drug has no efficacy and way up if it is a home run.
You will not be able to get out at 7 or in at 15 as circumstances apply.
A bear raid is not just a quick sell off by any means possible.
Here is the NASDAQ definition:
A "bear raid" is when short-sellers conspire to push down the price of a stock through coordinated short-selling or the spreading of false rumors (or both)."
We have not seen either the huge spike in short selling and/or the type of false rumors that would constitute a bear raid.
altwwod - There has not been a bear raid on PRAN. Posters using the term are simply trying to induce selling.
Most people on Yahoo message boards don't even know the definition.